ARCHIVES

AACR Cancels $7 Million Annual Meeting, Citing Fear of SARS in Toronto

This article is from The Cancer Letter archive.

Vol. 29 No. 14 | April 4, 2003

Download PDF Visit The Full Archive

Related Articles

Lenalidomide Found Effective For Lymphoma In Phase II Trial

December 26, 2008

NIH Spent $181.3 Million on PR Last Year; House Probe Prompts Analysis of Spending

July 12, 2013

NCI says SELECT study is close to full enrollment.

April 23, 2004

DCT Board Approves Concept Of Planning Grants For New Particle Therapy Equipment Development

August 7, 1981

Advisors Ok New RFP For Natural Product Large-Scale Production

March 6, 1992

SWOG Study To Test Predictive Value Of Circulating Tumor Cells In Breast Cancer

October 27, 2006